RBC Capital Markets initiates coverage on Tandem Diabetes Care (TNDM) with an Outperform rating and $65 price target, citing ...

Analyst Jeff Johnson from Robert W. Baird reiterated a Hold rating on Tandem Diabetes Care (TNDM – Research Report) and increased the ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery ...

An analyst issued the equivalent of a warning on Tandem Diabetes Care (NASDAQ: TNDM) stock on the second trading day of the ...

The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is ...

(NASDAQ:TNDM), a global insulin delivery and diabetes technology ... by expansion into the U.S. Type 1 market with a 40% pump penetration (Tandem has a one-third share), which is expected to ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) ...

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

大摩：维持Tandem Diabetes Care(TNDM.US)评级，由持股观望调整至持股观望评级, 目标价由45.00美元调整至45.00美元。 Tandem Diabetes Care（TNDM.US）公司简介 ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...